Effect of modafinil on pancreatic exocrine secretion in the rat. A comparison with methadone

Appia, 1984, Action du 5-thio-glucose sur la sécrétion pancréatique externe chez le rat. Comparaison avec le 2-désoxy-glucose, Gastroenterol. Clin. Biol., 8, 746 Basluji, 1988, Successful treatment of idiopathic hypersomnia and narcolepsy with modatinil, Prog. Neuropsychopharmacol. Biol. Psychiat., 12, 695, 10.1016/0278-5846(88)90014-0 Chariot, 1988, Central and peripheral inhihilion of exocrine pancreatic secretion by α2-adrenergic agonists in the rat, Pharmacol. Res. Commun., 20, 707, 10.1016/S0031-6989(88)80118-8 Chariot, 1987, Effect of modatinil on pancrealic exocrine secretion in rats. A comparison with adrafinil and related drugs, Fundam. Clin. Pharmacol., 1, 174, 10.1111/j.1472-8206.1987.tb00563.x Chariot, 1976, Détermination automatisée de très faibles concentrations de bicarbonate. Application au suc pancréatique, Ann. Biol. Clin., 34, 269 Chariot, 1983, Modulation of stimulated pancreatic secretion by sympathomimetic amines in the rat, Pharmacology, 26, 313, 10.1159/000137817 Chariot, 1981, Vagal non cholinergic stimulation of pancreatic secretion in rats, Gastroentérol. Clin. Biol., 5, 920 Dewailly, 1989, Adrafinil et ralentissement du sujet age institutionnalise: de la significativité statistiue à la pertinence clinique (resultat d'une etude multicentricue en double aveugle versus lacebol, Act. Med. Int. Pshytic., 6 Duteil, 1986, Catecholamines et locomotion indunte par einq autres stimulants, J. Pharmacol. (Paris), 17 Dutail, 1979, A possible anadrenergis mechanism for drug(CRL-40028)- induced hyperactivity, European J. Pharmacol., 59, 121, 10.1016/0014-2999(79)90033-5 Dutail, 1990, Central al adrenergic stimulation in relation to the behaviour stimulating effect of modatinil: studies with experminental animals, European J. Pharmacol., 180, 49, 10.1016/0014-2999(90)90591-S Hermant, 1991, Awakening properties of modatinil effect on nocturnal activity in monkey (Macaca mullata), Psycopharmacology, 103, 28, 10.1007/BF02244069 Israel, 1989, Olmiton et et patients ages ambulatoires. Efficacité. versus placebo. de Fadratinil sur Reveil dans les activities de la vie quotidienne, Psychol. Med., 21, 1235 Mithaud, 1985, Efects de l'adratinil sur l'activité nocturne du macaque rhesus (macaca mulatta), J. pharmacol. (Paris), 16, 372 Rambert, 1986, A unique Psycho-pharmacological profile of adratinil in mice, J. Pharmacol. (Paris), 17, 37 Rozé, 1981, Clonidine inhibition of pancreatic secretion in rats: a possible central site of action, European J. Pharmacol., 76, 381, 10.1016/0014-2999(81)90109-6 Rozé, 1978, Methadone blocked of 2-deoxyglucose induced pancreatic secretion in the rat: evidence for a central site of action, Gastroenterology, 44, 215, 10.1016/0016-5085(78)90799-0 Rozé, 1975, Technique d'étude de la sécrétion pancéatique externe chez le rat, Biol. Gastroentérol. (Paris), 8, 291 Saletu, 1989, Differential effects of a new central adrenergic agonist modatinil and d-amphetamine on sleep and early morning behaviour in young healthy volunteers, Int. J. Clin. Pharmacol. Res., 9, 183 Saletu, 1989, Differential effects of the new central adrenergic agonist modatinil and d-amphetamine on sleep and early morning behaviour in elderlies, Arzneim Forsch., 39, 1268 Saletu, 1990, On the treatment of the alcoholic organic brain syndrome with an α-adrenergic agonist. modafinil: double-blind, placebo-controlled clinical, psychometric and neurophysiological studies. Prog. Neuropsychopharmacol, Biol. Psychiat., 14, 195 Schneider, 1988, Evaluation de l'activité thérapeutique de l'adrafinil (Olmifon k) chez le malade ägé institutionnalisé, gräce à une échelle visualisée d'expression de l'autonomie: le géronte, La Revue Gériat, 13, 203